Specifically, decreased abundance of the Akkermansia genus was demonstrated to be correlated with post-acute COVID-19 patients, with concurrent increases in myeloid progenitor inhibitory factor 1 (MPIF-1) and interleukin (IL)-17 [76]. This evidence concerns the gene CCL23 and COVID-19.